COMMUNIQUÉS West-GlobeNewswire

Director/PDMR Shareholding

01/11/2018 - 17:15

Director/PDMR Shareholding November 1, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]

The Villages Health and elminda joint Study Receives Erickson Foundation Award for Excellence in Aging Research at 2018 APHA Annual Meeting

01/11/2018 - 17:12

HERZLIYA, Israel and THE VILLAGES, Fla., Nov. 01, 2018 (GLOBE NEWSWIRE) -- elminda Ltd., an emerging medical technology company dedicated to paving a path to better brain health by integrating big-data repositories, [...]

GPS Ankle Bracelet Private Rental Program Open to Applicants in Canada

01/11/2018 - 16:45

SafeTracks GPS Canada Inc. now offers an alternative to incarceration RED DEER, Alberta, Nov. 01, 2018 (GLOBE NEWSWIRE) -- It is no secret that Canadian remands and prisons are overcrowded. There is an opportunity for [...]

Apellis Pharmaceuticals Announces Poster Presentations at the American Society of Hematology Annual Meeting

01/11/2018 - 15:50

CRESTWOOD, Ky. and WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEF™ Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market

01/11/2018 - 15:35

MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution agreement with Iogen Oy [...]

ASLAN Pharmaceuticals to Present New Data on ASLAN003 at American Society of Hematology Annual Meeting

01/11/2018 - 15:20

SINGAPORE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]

The Alliance for Regenerative Medicine Releases Q3 2018 Data Report, Highlighting Sector Trends and Metrics

01/11/2018 - 15:17

WASHINGTON, DC , Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene [...]

NewLink Genetics Announces Oral Presentation at the 2018 American Society of Hematology (ASH) Annual Meeting

01/11/2018 - 15:00

AMES, Iowa, Nov. 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that an abstract with data pertaining to the use of the Company's investigational immuno-oncology molecule, [...]

TG Therapeutics, Inc. Announces Triple Therapy Data Presentations at the Upcoming 60th American Society of Hematology Annual Meeting and Exposition

01/11/2018 - 14:46

Investor and Analyst Event to be Held on Sunday December 2, 2018 at 7:30 PM PT at the Marriot Gaslamp San Diego with Presentations by Leading Clinical Investigators NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- TG [...]

Bavarian Nordic Announces Initiation of Phase 2 Trial of BN-Brachyury for the Treatment of Chordoma

01/11/2018 - 14:34

First dose has been administered in the multiple-center study BN-Brachyury for the treatment of chordoma received FDA Orphan Drug Designation in May 2018 COPENHAGEN, Denmark, November 1, 2018 - Bavarian Nordic A/S (OMX [...]

Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting

01/11/2018 - 14:26

SAN DIEGO and TORONTO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the [...]

Merit Medical to Present at Four Conferences in November

01/11/2018 - 14:25

SOUTH JORDAN, Utah, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting

01/11/2018 - 14:20

– Updated Single Agent Ivosidenib Data in Previously Untreated Acute Myeloid Leukemia (AML) Patients from Phase 1 Study Chosen for Oral Presentation – – Updated Data from Phase 1 Frontline AML Combination Study of [...]

Sunesis Pharmaceuticals Announces Presentations at 60th American Society of Hematology Annual Meeting

01/11/2018 - 14:17

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced two poster presentations and an oral presentation at the 60 th American Society of Hematology ( [...]

Affimed Announces Oral Presentation and Five Poster Presentations at the 2018 American Society of Hematology Annual Meeting

01/11/2018 - 14:16

Heidelberg, Germany, November 1, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of [...]

Genmab Announces Data to be Presented at 2018 ASH Annual Meeting

01/11/2018 - 14:16

Media Release Thirty-five total abstracts on Genmab owned and partnered programs scheduled for presentation at ASH Three abstracts related to Genmab owned programs: DuoBody ® -CD3xCD20 & DuoHexaBody™-CD37 [...]

Precipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing Workflows

01/11/2018 - 14:15

Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, Conn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: [...]

argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition

01/11/2018 - 14:15

Regulated information – Inside information 92% overall response rate with durability up to 14.4 months in ongoing analysis of Phase 1/2 trial Updated results from Phase 1/2 trial of cusatuzumab in CTCL also published [...]

Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting

01/11/2018 - 14:05

HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]